USANA Health Sciences Stock Price and Value Analysis

USANA Health Sciences (NYSE:USNA) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold USANA Health Sciences to reach your target.

Target type

USNA Free Cash Flow Trend

Free Cash Flow trendline for USNA
Free Cash Flow trendline for USANA Health Sciences
CSV

Based on historical returns, we believe that USANA Health Sciences can grow its free cash at a rate of about 36%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a great rate!
  • This company is solid.
  • This stock is available at a great discount!
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the USNA Numbers

USNA Price
(USANA Health Sciences stock price per share)
$12.89
[?] USNA Fair Price
(based on intrinsic value)
$812.79
[?] USNA Safety Price (based on a variable margin of safety) $528.31
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 110% higher than other Healthcare stocks
[?] PE Ratio versus Industry 16% higher than other Drug Manufacturers - Specialty & Generic stocks
[?] Cash Yield 40.85%
[?] Free Cash Flow Jitter 41%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 879,205 shares shorted. With 9,930,836 shares available for purchase and an average trading volume over the past 10 trading days of 226,300, it would take at least 3.9 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 896264 28.3
2010 896264 61.9
2011 896264 63.8
2012 896264 86.0
2013 896264 91.8
2014 896264 94.8
2015 896264 97.2
2016 896264 118.2
2017 896264 104.2
2018 896264 131.8
2019 896264 107.2
2020 896264 142.6
2021 896264 107.4
2022 896264 90.7
2023 896264 56.8
2024 896264 48.4
2025 896264 10.0

Download the yearly data as CSV.

Price Versus Our Estimated Value

With the price at $12.89, USANA Health Sciences is below both our safe value ($528.31) and our fair value ($812.79).

Every one of the 17 fiscal years we have for USANA Health Sciences under its current filer shows positive free cash flow.

USANA Health Sciences's average free cash flow fell sharply, from $51.4 million in its earliest three years to $38.4 million in its latest three.

Free cash flow is volatile from year to year, with a variability measure of 41%.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

No dividend yield is recorded for USANA Health Sciences in our data.

Compared With Its Sector and Industry

Its trailing P/E ratio is 110% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 16% above the average for stocks in the Drug Manufacturers - Specialty & Generic industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 896264.

Each figure on this page comes from that filer.

Risks to This Analysis

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in USNA

Does USANA Health Sciences have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: USNA

This example shows how we apply the Trendshare checklist to USNA: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 12.89
    • Market cap: $238M
    • EPS: -1.14
  2. Step 2 — Valuation checks

    • P/E: —
    • FCF yield: 40.8%
    • Date checked: Nov 12, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.